| 1 |
Xia C, Li X, Wu Y, Suharti S, Unpaprom Y, Pugazhendhi A. A review on pollutants remediation competence of nanocomposites on contaminated water. Environ Res 2023;222:115318. [PMID: 36693465 DOI: 10.1016/j.envres.2023.115318] [Reference Citation Analysis]
|
| 2 |
Sankar Satapathy B, Pattnaik S, Keshari Biswal S, Biswal B, Kumar Sahoo P, Bhusan Samal H, Barik B. Recent Advancements in Phyto Component Based Nanocarriers for Improved Treatment of Brain Disorders. Drug Repurposing - Advances, Scopes and Opportunities in Drug Discovery [Working Title] 2023. [DOI: 10.5772/intechopen.110585] [Reference Citation Analysis]
|
| 3 |
Khan Z, Abourehab MAS, Parveen N, Kohli K, Kesharwani P. Recent advances in microbeads-based drug delivery system for achieving controlled drug release. J Biomater Sci Polym Ed 2023;34:541-64. [PMID: 36168111 DOI: 10.1080/09205063.2022.2127237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Parveen N, Sheikh A, Abourehab MA, Karwasra R, Singh S, Kesharwani P. Self-nanoemulsifying drug delivery system for pancreatic cancer. European Polymer Journal 2023. [DOI: 10.1016/j.eurpolymj.2023.111993] [Reference Citation Analysis]
|
| 5 |
Jagdale S, Narwade M, Sheikh A, Md S, Salve R, Gajbhiye V, Kesharwani P, Gajbhiye KR. GLUT1 transporter-facilitated solid lipid nanoparticles loaded with anti-cancer therapeutics for ovarian cancer targeting. International Journal of Pharmaceutics 2023. [DOI: 10.1016/j.ijpharm.2023.122894] [Reference Citation Analysis]
|
| 6 |
Parveen N, Abourehab MAS, Thanikachalam PV, Khar RK, Kesharwani P. Nanocrystals as an emerging nanocarrier for the management of dermatological diseases. Colloids Surf B Biointerfaces 2023;225:113231. [PMID: 36907135 DOI: 10.1016/j.colsurfb.2023.113231] [Reference Citation Analysis]
|
| 7 |
Căta A, Ienașcu IMC, Ştefănuț MN, Roșu D, Pop OR. Properties and Bioapplications of Amphiphilic Janus Dendrimers: A Review. Pharmaceutics 2023;15. [PMID: 36839911 DOI: 10.3390/pharmaceutics15020589] [Reference Citation Analysis]
|
| 8 |
Hasan N, Imran M, Nadeem M, Jain D, Haider K, Moshahid Alam Rizvi M, Sheikh A, Kesharwani P, Kumar Jain G, Jalees Ahmad F. Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer. Int J Pharm 2023;632:122580. [PMID: 36608807 DOI: 10.1016/j.ijpharm.2022.122580] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Parveen N, Abourehab MA, Shukla R, Thanikachalam PV, Jain GK, Kesharwani P. Immunoliposomes as an emerging nanocarrier for breast cancer therapy. European Polymer Journal 2023;184:111781. [DOI: 10.1016/j.eurpolymj.2022.111781] [Reference Citation Analysis]
|
| 10 |
Rehman U, Abourehab MA, Alexander A, Kesharwani P. Polymeric micelles assisted combinatorial therapy: Is it new hope for pancreatic cancer? European Polymer Journal 2023;184:111784. [DOI: 10.1016/j.eurpolymj.2022.111784] [Reference Citation Analysis]
|
| 11 |
Aziz A, Rehman U, Sheikh A, Abourehab MAS, Kesharwani P. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy. J Biomater Sci Polym Ed 2023;34:398-418. [PMID: 36083788 DOI: 10.1080/09205063.2022.2121592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Fu X, Rehman U, Wei L, Chen ZS, Abourehab MAS, Kesharwani P, Cheng ZH. Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyond. Drug Resist Updat 2023;68:100935. [PMID: 36774747 DOI: 10.1016/j.drup.2023.100935] [Reference Citation Analysis]
|
| 13 |
Zeng L, Gowda BHJ, Ahmed MG, Abourehab MAS, Chen ZS, Zhang C, Li J, Kesharwani P. Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Mol Cancer 2023;22:10. [PMID: 36635761 DOI: 10.1186/s12943-022-01708-4] [Reference Citation Analysis]
|
| 14 |
Liu Z, Parveen N, Rehman U, Aziz A, Sheikh A, Abourehab MAS, Guo W, Huang J, Wang Z, Kesharwani P. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Mol Cancer 2023;22:8. [PMID: 36635659 DOI: 10.1186/s12943-022-01696-5] [Reference Citation Analysis]
|
| 15 |
Mostovaya O, Shiabiev I, Pysin D, Stanavaya A, Abashkin V, Shcharbin D, Padnya P, Stoikov I. PAMAM-Calix-Dendrimers: Second Generation Synthesis, Fluorescent Properties and Catecholamines Binding. Pharmaceutics 2022;14. [PMID: 36559243 DOI: 10.3390/pharmaceutics14122748] [Reference Citation Analysis]
|
| 16 |
Syed MH, Zahari MAKM, Khan MMR, Beg MDH, Abdullah N. An overview on recent biomedical applications of biopolymers: Their role in drug delivery systems and comparison of major systems. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104121] [Reference Citation Analysis]
|
| 17 |
Shiabiev IE, Pysin DA, Padnya PL, Stoikov II. First-Generation Dendrimers Based on Thiacalix[4]arene Containing Hydroxyl Terminal Groups: Synthesis and Self-Assembly. Russ J Gen Chem 2022;92:2574-2581. [DOI: 10.1134/s1070363222120040] [Reference Citation Analysis]
|
| 18 |
Khan Z, Alhalmi A, Tyagi N, Khan WU, Sheikh A, Abourehab MAS, Kohli K, Kesharwani P. Folic acid engineered sulforaphane loaded microbeads for targeting breast cancer. Journal of Biomaterials Science, Polymer Edition 2022. [DOI: 10.1080/09205063.2022.2144692] [Reference Citation Analysis]
|
| 19 |
Musyuni P, Bai J, Sheikh A, Vasanthan KS, Jain GK, Abourehab MA, Lather V, Aggarwal G, Kesharwani P, Pandita D. Precision Medicine: Ray of Hope in Overcoming Cancer Multidrug Resistance. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100889] [Reference Citation Analysis]
|
| 20 |
Arora V, Abourehab MA, Modi G, Kesharwani P. Dendrimers as prospective nanocarrier for targeted delivery against lung cancer. European Polymer Journal 2022;180:111635. [DOI: 10.1016/j.eurpolymj.2022.111635] [Reference Citation Analysis]
|
